The Rise of "Eco-Friendly" Manufacturing in the Atorvastatin API Market
Sustainability has officially moved from a "Corporate Goal" to a "Mechanical Necessity" this year. In 2026, the Atorvastatin API Market is being reshaped by new "Environmental, Social, and Governance" (ESG) mandates from major healthcare buyers. Hospitals and government health systems are now including "Carbon Footprint" scores in their procurement scores, meaning that a manufacturer’s...
0 Комментарии
0 Поделились
246 Просмотры